Outset Medical, Inc. (OM)
NASDAQ: OM · Real-Time Price · USD
4.320
-0.090 (-2.04%)
At close: Apr 28, 2026, 4:00 PM EDT
4.250
-0.070 (-1.62%)
After-hours: Apr 28, 2026, 7:24 PM EDT
Outset Medical Revenue
In the year 2025, Outset Medical had annual revenue of $119.48M with 5.09% growth. Outset Medical had revenue of $28.87M in the quarter ending December 31, 2025, a decrease of -2.01%.
Revenue (ttm)
$119.48M
Revenue Growth
+5.09%
P/S Ratio
0.66
Revenue / Employee
$385,406
Employees
310
Market Cap
79.11M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 119.48M | 5.79M | 5.09% |
| Dec 31, 2024 | 113.69M | -16.69M | -12.80% |
| Dec 31, 2023 | 130.38M | 15.00M | 13.00% |
| Dec 31, 2022 | 115.38M | 12.77M | 12.45% |
| Dec 31, 2021 | 102.60M | 52.67M | 105.47% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Sep 30, 2013 | Pro | Pro | Pro |
| Sep 30, 2012 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Xtant Medical Holdings | 133.93M |
| LENSAR | 58.44M |
| Rapid Micro Biosystems | 33.59M |
| MaxCyte | 33.03M |
| Sensus Healthcare | 27.48M |
| Baird Medical Investment Holdings | 22.54M |
| Spectral AI | 19.65M |
| QT Imaging Holdings | 18.93M |
OM News
- 1 day ago - Outset Medical to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026 - GlobeNewsWire
- 15 days ago - Did Outset Medical, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - PRNewsWire
- 20 days ago - Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 22 days ago - Outset Medical Names Derick Elliott as Executive Vice President of Commercial - GlobeNewsWire
- 2 months ago - Outset Medical Earnings Call Transcript: Q4 2025 - Transcripts
- 2 months ago - Outset Medical Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 3 months ago - Next-Generation Tablo Hemodialysis System Receives FDA Clearance, Second Quarter Launch Planned - GlobeNewsWire
- 3 months ago - Outset Medical to Report Fourth Quarter 2025 Financial Results on Wednesday, February 11, 2026 - GlobeNewsWire